Addex Therapeutics Ltd - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
ADXN Nasdaq 2830 www.addextherapeutics.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Addex Therapeutics Ltd

Addex Announces Publication of Research Highlighting Therapeutic Potential of mGlu7 Modulation in Regulating Sleep and Wakefulness - Jul 7th, 2026 11:00 pm
Addex Shareholders Approve All Resolutions at Annual General Meeting - Jun 29th, 2026 11:00 pm
Addex Therapeutics Ltd (ADXN) Q1 2026 Earnings Call Highlights: Strategic Advances Amid ... - Jun 25th, 2026 3:00 pm
Addex Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update - Jun 24th, 2026 11:00 pm
Addex Therapeutics to Report 2026 First Quarter Financial Results and Host Conference Call on June 25, 2026 - Jun 21st, 2026 11:00 pm
Addex Convenes Annual General Meeting 2026 - Jun 4th, 2026 11:00 pm
Addex Reports Full Year 2025 Financial Results and Provides Corporate Update - Apr 29th, 2026 11:00 pm
Addex Spin-Out Company Neurosterix on Track to Complete Phase 1 Clinical Study of NTX-253 for Schizophrenia in Q2 2026 - Apr 22nd, 2026 11:00 pm
Addex Announces Publication of Preclinical Data Supporting Potential of mGlu7 Negative Allosteric Modulators to Transform Anxiety and Fear-Related Disorder Treatment - Feb 2nd, 2026 11:00 pm
Addex Therapeutics Ltd (ADXN) Q2 2025 Earnings Call Highlights: Strategic Advances Amid ... - Oct 1st, 2025 3:01 pm